Dave Pattison (@drdavepattison) 's Twitter Profile
Dave Pattison

@drdavepattison

Nuclear medicine / theranostics specialist (NETs, prostate & thyroid cancer), father, runner, surfer & small batch coffee grower. Views expressed are my own.

ID: 1442628153214595072

calendar_today27-09-2021 23:12:19

34 Tweet

101 Followers

55 Following

Michael Hofman (@drmhofman) 's Twitter Profile Photo

JNM State-of-the-Art: The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective jnm.snmjournals.org/content/63/6/8… Louise Emmett Sze Ting Lee SNMMI Theranostics AANMS

<a href="/JournalofNucMed/">JNM</a> State-of-the-Art: The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
jnm.snmjournals.org/content/63/6/8…
<a href="/drlouiseemmett/">Louise Emmett</a> <a href="/szetinglee1/">Sze Ting Lee</a> <a href="/SNM_MI/">SNMMI</a> <a href="/TheranosticsAus/">Theranostics AANMS</a>
JNM (@journalofnucmed) 's Twitter Profile Photo

That's how you do it: The Australian perspective on importance of training, accreditation, and guidelines for the practice of theranostics. ow.ly/uUlp50Jo1Ht #Theranostics = #PrecisionOncology Sze Ting Lee

European Urology Oncology (@eururoloncol) 's Twitter Profile Photo

Current Issue: All Prostate-specific Membrane Antigen Peptides Are Equal, but Some Are More Equal than Others buff.ly/38TvGEe Louise Emmett Dave Pattison #prostate #urology #oncology #MedTwitter

Current Issue: All Prostate-specific Membrane Antigen Peptides Are Equal, but Some Are More Equal than Others

buff.ly/38TvGEe

<a href="/drlouiseemmett/">Louise Emmett</a> <a href="/DrDavePattison/">Dave Pattison</a> 

#prostate #urology #oncology #MedTwitter
THANC Foundation (@thancfoundation) 's Twitter Profile Photo

Attention #ThyroidSpecialists! Please join us for our next International #Thyroid #TumorBoard this Fri @ 8 AM EDT! Dr. Michael Tuttle of @sloan_kettering will serve as the moderator. #MedTwitter #MedEd #ThyroidCancer #ThyroidSurgery #EndoTwitter #CancerTreatment #Cancer

Attention #ThyroidSpecialists! Please join us for our next International #Thyroid #TumorBoard this Fri @ 8 AM EDT! Dr. Michael Tuttle of @sloan_kettering will serve as the moderator. 

#MedTwitter #MedEd #ThyroidCancer #ThyroidSurgery #EndoTwitter #CancerTreatment #Cancer
Australasian Assoc of Nuclear Medicine Specialists (@ausnucmed) 's Twitter Profile Photo

Reminder - early bird closes in one weeks time, 15 July 2022. Don't miss the opportunity to attend this course with over 20 expert speakers in Theranostics. Register here - bit.ly/39pZHfQ

Reminder - early bird closes in one weeks time, 15 July 2022.  Don't miss the opportunity to attend this course with over 20 expert speakers in Theranostics.
Register here -   bit.ly/39pZHfQ
Michael Hofman (@drmhofman) 's Twitter Profile Photo

LuDOTATATE vs sunitinib in pancreatic NET 1yr PFS: 80.5% vs 42%. Large difference favouring PRRT. And, much less G3/4 toxicity 44% vs 63%. 80 pt study: a lot can be achieved with small studies with effect size is large. OCLURANDOM trial ESMO - Eur. Oncology

Dr Matthew Accatino (né Balcerek) (@matthewbalcerek) 's Twitter Profile Photo

CAR-T therapy has proven successful in haematological malignancies; does it hold promise in metastatic medullary #thyroid cancer? Find out in this commentary written with A/Prof McLeod and A/Prof Siok Tey for Clinical Thyroidology #ClinicalThyroidology doi.org/10.1089/ct.202…

Michael Hofman (@drmhofman) 's Twitter Profile Photo

Lutetium-177 PSMA Theranostics: Optimal Sequencing in 2023 and Future Outlook dailynews.ascopubs.org/do/10.1200/ADN… #ASCODailyNews ASCO Rapidly changing landscape: what do you think is next?

Jeremie Calais (@calaisjeremie) 's Twitter Profile Photo

The new PSG score is a PSMA-PET Whole-Body Tumor-to-Salivary Gland Ratio to estimate the target expression at the whole body level using the PET MIP to Predict Response to 177Lu-PSMA (PLUVICTO). Tested by 10 international experts on 237 patients. jnm.snmjournals.org/content/early/…

The new PSG score is a PSMA-PET Whole-Body Tumor-to-Salivary Gland Ratio to estimate the target expression at the whole body level using the PET MIP to Predict Response to 177Lu-PSMA (PLUVICTO). Tested by 10 international experts on 237 patients. jnm.snmjournals.org/content/early/…
Michael Hofman (@drmhofman) 's Twitter Profile Photo

🌐 Discover the future of #ProstateCancer theranostics with world-class experts. 💡 Discussing Alpha #PSMA, new targets, & neuroendocrine challenges. Your voice matters - join us for a live Q&A! 🗓️July 19, 1PM PST / 9PM CET. ✨Register now: unimelb.zoom.us/webinar/regist…

🌐 Discover the future of #ProstateCancer theranostics with world-class experts. 💡 Discussing Alpha #PSMA, new targets, &amp; neuroendocrine challenges. Your voice matters - join us for a live Q&amp;A!

🗓️July 19, 1PM PST / 9PM CET. ✨Register now: unimelb.zoom.us/webinar/regist…
Theranostics AANMS (@theranosticsaus) 's Twitter Profile Photo

Please join us for our first interactive online and complimentary Theranostics course available to the #nuclearmedicine community. #theranostics #expertplanel #prostatecancer #onlinecasestudies #seriesoneofmany

Please join us for our first interactive online and complimentary Theranostics course available to the #nuclearmedicine community. #theranostics #expertplanel #prostatecancer #onlinecasestudies
#seriesoneofmany
Australasian Assoc of Nuclear Medicine Specialists (@ausnucmed) 's Twitter Profile Photo

⭐Dont miss this webinar - the first of our quarterly interactive sessions. ⭐Ask our expert panel online questions and participate in the polls. ⭐Log in via the link or QR code. ⭐Monday 17 July 2023, 7.30 pm (AEST) #nuclearmedicine #theranostics

⭐Dont miss this webinar - the first of our quarterly 
        interactive sessions. 
⭐Ask our expert panel online questions and 
       participate in the polls.
⭐Log in via the link or QR code.
⭐Monday 17 July 2023, 7.30 pm (AEST)
#nuclearmedicine #theranostics
Michael Hofman (@drmhofman) 's Twitter Profile Photo

🌐Now on ProsTIC TV: Explore New Frontiers of Prostate Cancer Theranostics webinar. Deep dive on alpha + new targets. 1000+ registrants from 75 countries! 🔗youtube.com/@ProsTICTV/?su… PCF Science ProsTIC GU Cast | Urology podcast! Also on #GuCast

🌐Now on ProsTIC TV: Explore New Frontiers of Prostate Cancer Theranostics webinar. Deep dive on alpha + new targets. 1000+ registrants from 75 countries!
🔗youtube.com/@ProsTICTV/?su…
<a href="/PCF_Science/">PCF Science</a> <a href="/pros_tic/">ProsTIC</a> <a href="/gu_onc/">GU Cast | Urology podcast!</a> 
Also on #GuCast